As the global economy mends, the 2021 growth of Killed-type Poultry Vaccine will have significant change from previous year. According to our (Publisher) latest study, the global Killed-type Poultry Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Killed-type Poultry Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Killed-type Poultry Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Killed-type Poultry Vaccine market, reaching US$ million by the year 2028. As for the Europe Killed-type Poultry Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Killed-type Poultry Vaccine players cover MERCK, Boehringer Ingelheim, CEVA, and ZOETIS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Killed-type Poultry Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Chicken
Other Poultry
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
MERCK
Boehringer Ingelheim
CEVA
ZOETIS
Vaxxinova
ELANCO
QYH BIOTECH
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
VENKY'S
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Killed-type Poultry Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Killed-type Poultry Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Killed-type Poultry Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Killed-type Poultry Vaccine Segment by Type
2.2.1 NDV
2.2.2 Marek ' s Disease
2.2.3 IBD
2.2.4 Infectious Bronchitis
2.2.5 Influenza
2.2.6 Other
2.3 Killed-type Poultry Vaccine Sales by Type
2.3.1 Global Killed-type Poultry Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Killed-type Poultry Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Killed-type Poultry Vaccine Sale Price by Type (2017-2022)
2.4 Killed-type Poultry Vaccine Segment by Application
2.4.1 Chicken
2.4.2 Other Poultry
2.5 Killed-type Poultry Vaccine Sales by Application
2.5.1 Global Killed-type Poultry Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Killed-type Poultry Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Killed-type Poultry Vaccine Sale Price by Application (2017-2022)
3 Global Killed-type Poultry Vaccine by Company
3.1 Global Killed-type Poultry Vaccine Breakdown Data by Company
3.1.1 Global Killed-type Poultry Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Killed-type Poultry Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Killed-type Poultry Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Killed-type Poultry Vaccine Revenue by Company (2020-2022)
3.2.2 Global Killed-type Poultry Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Killed-type Poultry Vaccine Sale Price by Company
3.4 Key Manufacturers Killed-type Poultry Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Killed-type Poultry Vaccine Product Location Distribution
3.4.2 Players Killed-type Poultry Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Killed-type Poultry Vaccine by Geographic Region
4.1 World Historic Killed-type Poultry Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Killed-type Poultry Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Killed-type Poultry Vaccine Annual Revenue by Geographic Region
4.2 World Historic Killed-type Poultry Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Killed-type Poultry Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Killed-type Poultry Vaccine Annual Revenue by Country/Region
4.3 Americas Killed-type Poultry Vaccine Sales Growth
4.4 APAC Killed-type Poultry Vaccine Sales Growth
4.5 Europe Killed-type Poultry Vaccine Sales Growth
4.6 Middle East & Africa Killed-type Poultry Vaccine Sales Growth
5 Americas
5.1 Americas Killed-type Poultry Vaccine Sales by Country
5.1.1 Americas Killed-type Poultry Vaccine Sales by Country (2017-2022)
5.1.2 Americas Killed-type Poultry Vaccine Revenue by Country (2017-2022)
5.2 Americas Killed-type Poultry Vaccine Sales by Type
5.3 Americas Killed-type Poultry Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Killed-type Poultry Vaccine Sales by Region
6.1.1 APAC Killed-type Poultry Vaccine Sales by Region (2017-2022)
6.1.2 APAC Killed-type Poultry Vaccine Revenue by Region (2017-2022)
6.2 APAC Killed-type Poultry Vaccine Sales by Type
6.3 APAC Killed-type Poultry Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Killed-type Poultry Vaccine by Country
7.1.1 Europe Killed-type Poultry Vaccine Sales by Country (2017-2022)
7.1.2 Europe Killed-type Poultry Vaccine Revenue by Country (2017-2022)
7.2 Europe Killed-type Poultry Vaccine Sales by Type
7.3 Europe Killed-type Poultry Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Killed-type Poultry Vaccine by Country
8.1.1 Middle East & Africa Killed-type Poultry Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Killed-type Poultry Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Killed-type Poultry Vaccine Sales by Type
8.3 Middle East & Africa Killed-type Poultry Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Killed-type Poultry Vaccine
10.3 Manufacturing Process Analysis of Killed-type Poultry Vaccine
10.4 Industry Chain Structure of Killed-type Poultry Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Killed-type Poultry Vaccine Distributors
11.3 Killed-type Poultry Vaccine Customer
12 World Forecast Review for Killed-type Poultry Vaccine by Geographic Region
12.1 Global Killed-type Poultry Vaccine Market Size Forecast by Region
12.1.1 Global Killed-type Poultry Vaccine Forecast by Region (2023-2028)
12.1.2 Global Killed-type Poultry Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Killed-type Poultry Vaccine Forecast by Type
12.7 Global Killed-type Poultry Vaccine Forecast by Application
13 Key Players Analysis
13.1 MERCK
13.1.1 MERCK Company Information
13.1.2 MERCK Killed-type Poultry Vaccine Product Offered
13.1.3 MERCK Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 MERCK Main Business Overview
13.1.5 MERCK Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Killed-type Poultry Vaccine Product Offered
13.2.3 Boehringer Ingelheim Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 CEVA
13.3.1 CEVA Company Information
13.3.2 CEVA Killed-type Poultry Vaccine Product Offered
13.3.3 CEVA Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CEVA Main Business Overview
13.3.5 CEVA Latest Developments
13.4 ZOETIS
13.4.1 ZOETIS Company Information
13.4.2 ZOETIS Killed-type Poultry Vaccine Product Offered
13.4.3 ZOETIS Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 ZOETIS Main Business Overview
13.4.5 ZOETIS Latest Developments
13.5 Vaxxinova
13.5.1 Vaxxinova Company Information
13.5.2 Vaxxinova Killed-type Poultry Vaccine Product Offered
13.5.3 Vaxxinova Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Vaxxinova Main Business Overview
13.5.5 Vaxxinova Latest Developments
13.6 ELANCO
13.6.1 ELANCO Company Information
13.6.2 ELANCO Killed-type Poultry Vaccine Product Offered
13.6.3 ELANCO Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 ELANCO Main Business Overview
13.6.5 ELANCO Latest Developments
13.7 QYH BIOTECH
13.7.1 QYH BIOTECH Company Information
13.7.2 QYH BIOTECH Killed-type Poultry Vaccine Product Offered
13.7.3 QYH BIOTECH Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 QYH BIOTECH Main Business Overview
13.7.5 QYH BIOTECH Latest Developments
13.8 PULIKE
13.8.1 PULIKE Company Information
13.8.2 PULIKE Killed-type Poultry Vaccine Product Offered
13.8.3 PULIKE Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 PULIKE Main Business Overview
13.8.5 PULIKE Latest Developments
13.9 PHIBRO ANIMAL HEALTH CORPORATION
13.9.1 PHIBRO ANIMAL HEALTH CORPORATION Company Information
13.9.2 PHIBRO ANIMAL HEALTH CORPORATION Killed-type Poultry Vaccine Product Offered
13.9.3 PHIBRO ANIMAL HEALTH CORPORATION Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 PHIBRO ANIMAL HEALTH CORPORATION Main Business Overview
13.9.5 PHIBRO ANIMAL HEALTH CORPORATION Latest Developments
13.10 JINYU BIOTECHNOLOGY
13.10.1 JINYU BIOTECHNOLOGY Company Information
13.10.2 JINYU BIOTECHNOLOGY Killed-type Poultry Vaccine Product Offered
13.10.3 JINYU BIOTECHNOLOGY Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 JINYU BIOTECHNOLOGY Main Business Overview
13.10.5 JINYU BIOTECHNOLOGY Latest Developments
13.11 HARBIN PHARMACEUTICAL GROUP
13.11.1 HARBIN PHARMACEUTICAL GROUP Company Information
13.11.2 HARBIN PHARMACEUTICAL GROUP Killed-type Poultry Vaccine Product Offered
13.11.3 HARBIN PHARMACEUTICAL GROUP Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 HARBIN PHARMACEUTICAL GROUP Main Business Overview
13.11.5 HARBIN PHARMACEUTICAL GROUP Latest Developments
13.12 MEVAC
13.12.1 MEVAC Company Information
13.12.2 MEVAC Killed-type Poultry Vaccine Product Offered
13.12.3 MEVAC Killed-type Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 MEVAC Main Business Overview
13.12.5 MEVAC Latest Developments
13.13 VENKY